Insider buying · SEC Form 4

Insider Buying — Jul 31, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

3insider buys
$16.0Mbought in total
3companies
2by CEOs, CFOs and other chiefs
MPLTlargest: $15.3M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
MPLTMapLight Therapeutics, Inc.Catalyst4, Inc.10% Owner$15.3M1,209,225$12.66AddedJul 30, 2026
Form 4 ↗
Bought 1,209,225 shares across 4 transactions Jul 28–30 at prices ranging $10.74–$13.00 (avg ~$12.66); stock now $14.03 (+10.8%). Stock hit all-time low $9.10 on Jul 28. Positive Phase 2 ZEPHYR results Jul 27. Director Troy Cox also bought $149K on Jul 28 (below threshold). Catalyst4 held ~19.7M shares pre-purchase; post-purchase 20.9M shares.
ACIAlbertsons Companies, Inc.Susan MorrisCEO$450K39,409$11.42AddedJul 30, 2026
Form 4 ↗
Bought 39,409 shares at prices ranging $11.377–$11.455 (avg $11.42) on Jul 28; stock now $11.60 (+1.6%). Cluster: EVP Thomas Moriarty bought $1.96M at $11.51 on Jul 27 (filed Jul 28). Combined two-day cluster buy ~$2.4M near multi-year lows.
NMMNavios Maritime Partners L.P.Angeliki FrangouCEO & Chairwoman$251K3,191$78.50AddedJul 30, 2026
Form 4 ↗
3 tranches: Jul 28 (1,072 @ $78.59), Jul 29 (1,051 @ $78.55), Jul 30 (1,068 @ $78.37); stock now $79.27 (+0.9%). Executed via Rule 10b5-1 plan adopted Dec 9, 2025 through affiliated entity Raymar Investments S.A. Systematic accumulation — reduced signal value vs. discretionary buy.

AIThe day in insider buying

SEC Form 4 Insider Scan — July 31, 2026

Scanned the last 24 hours of EDGAR Form 4 filings (filed July 30–31, 2026). 3 qualifying buys (≥ $250K, transaction type P) totalling $16.0M.

Headline Filings

  • MPLT — Catalyst4, Inc. (10% Owner) bought 1,209,225 shares ≈ $15.3M at $12.66 avg over Jul 28–30; now $14.03 (+10.8% since buy). (filing)
  • ACI — Susan Morris (CEO, Albertsons) bought 39,409 shares ≈ $450K at $11.42 avg on Jul 28; now $11.60 (+1.6% since buy). Companion to EVP Moriarty's $1.96M buy filed Jul 28. (filing)
  • NMM — Angeliki Frangou (CEO & Chairwoman, Navios Maritime Partners) bought 3,191 units ≈ $251K at $78.52 avg over Jul 28–30; now $79.27 (+0.9% since buy). 10b5-1 plan via affiliated entity. (filing)

Notes

Thin buying day overall — scanning 1,600+ Form 4 filings yielded only 3 open-market purchases above $250K. The vast majority were routine RSU grants (code A), option exercises (code M), insider sales (code S), and pre-arranged 10b5-1 disposals.

MPLT dominates at $15.3M: MapLight Therapeutics (CNS biotech, NASDAQ) saw 10% owner Catalyst4 aggressively accumulate near all-time lows ($9.10 on Jul 28). Stock has already recovered to $14.03 as of Jul 31, putting Catalyst4 up +10.8% on the position. Positive Phase 2 ZEPHYR trial results were reported Jul 27. Director Troy Cox also made an open-market buy of $149K on Jul 28 (below $250K threshold — noted for cluster context). Heavy buying signal at the lows.

ACI cluster forming: Albertsons CEO Susan Morris's $450K buy on Jul 28 follows EVP of M&A Thomas Moriarty's $1.96M buy on Jul 27 (filed Jul 28 — just outside our 24-hour window). Two Albertsons insiders bought a combined ~$2.4M in two consecutive days near $11.40–$11.51 — the stock has been under sustained pressure following the collapse of the Kroger merger. Stock now at $11.60, barely above the buy zone.

NMM/Frangou is systematic: Purchased through a Rule 10b5-1 trading plan adopted December 9, 2025, via affiliate Raymar Investments S.A. Routine accumulation — lower signal value than a discretionary buy, but Frangou has a long history of conviction buying in Navios entities.

Close misses: LBRT Director Arjun N. Murti bought 14,053 shares at $17.79 avg on Jul 28 (total: $249,909 — just $91 below the $250K threshold). SCTX (Scribe Therapeutics) saw massive IPO-related buys by OrbiMed ($15M) and Carl Gordon ($15M) on Jul 27 filed Jul 29 — outside our 24-hour window but notable for the sector.

Most-bought stocks, last 30 days

  • AVO $60.1M · 8 buysMission Produce, Inc.
  • SCTX $56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
  • COE $26.7M · 3 buys, 2 insiders51Talk Online Education Group
  • MPLT $15.3M · 1 buyMapLight Therapeutics, Inc.
  • FLUT $11.8M · 1 buyFlutter Entertainment plc
  • NTSK $7.53M · 2 buys, 2 insidersNetskope Inc.
  • PBLS $6.92M · 1 buyParabilis Medicines, Inc.
  • HDSN $6.49M · 3 buys, 2 insidersHudson Technologies, Inc.
  • NVCT $4.66M · 8 buys, 2 insidersNuvectis Pharma, Inc.
  • GLOO $3.50M · 1 buyGloo Holdings, Inc.
  • ARTV $2.58M · 1 buyArtiva Biotherapeutics, Inc.
  • ACI $2.41M · 2 buys, 2 insidersAlbertsons Companies, Inc.
  • WBX $2.25M · 2 buys, 2 insidersWallbox N.V.
  • CLBK $2.13M · 5 buys, 5 insidersColumbia Financial, Inc.
  • GGAL $2.09M · 1 buyGrupo Financiero Galicia S.A.
  • ENR $2.02M · 1 buyEnergizer Holdings, Inc.
  • RH $1.83M · 1 buyRH
  • JCTC $1.61M · 2 buys, 2 insidersJewett-Cameron Trading Co. Ltd.
  • FULC $1.48M · 2 buys, 2 insidersFulcrum Therapeutics, Inc.
  • BOLD $1.25M · 3 buys, 2 insidersBoundless Bio, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.